title: Surrogate endpoints for new colorectal cancer drugs.
authors.forename: A
authors.initials: A
authors.lastname: Croockewit
authors.forename: J
authors.initials: J
authors.lastname: Schellens
authors.forename: H
authors.initials: H
authors.lastname: van Bronswijk
authors.forename: J F
authors.initials: JF
authors.lastname: Lekkerkerker
authors.forename: P P
authors.initials: PP
authors.lastname: Koopmans
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005467:Floxuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
chemical_list: D005467:Floxuridine; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate